02157 樂普生物－Ｂ
按盘价 
6.110 +0.770 (+14.419%) 盈利能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 资产回报率 (%) | 9.715% | -17.637% | -0.899% | -29.886% | -44.877% |
| 股东资金回报率 (%) | 25.021% | -51.431% | -2.458% | -79.316% | -87.524% |
| 资本运用回报率 (%) | 13.489% | -33.251% | -1.488% | -40.884% | -65.949% |
边际利润分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 毛利率 (%) | 90.417% | 79.656% | 87.452% | 87.124% | N/A |
| 未计利息、税项、折旧及摊销前利润率 (%) | 40.525% | -79.008% | 47.645% | -3911.097% | N/A |
| 税前边际利润率 (%) | 27.879% | -115.334% | -13.446% | -4491.658% | N/A |
| 纯利率 (%) | 27.957% | -111.850% | -9.805% | -4424.942% | N/A |
变现能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 流动比率 (X) | 0.983 X | 0.619 X | 0.753 X | 0.963 X | 0.572 X |
| 速动比率 (X) | 0.938 X | 0.597 X | 0.720 X | 0.935 X | 0.528 X |
财务杠杆分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 总负债 / 总资产比率 (%) | 56.034% | 70.105% | 62.727% | 64.385% | 59.315% |
| 总债项 / 总资产比率 (%) | 34.135% | 36.839% | 31.110% | 27.027% | 15.905% |
| 净债项 / 总资产比率 (%) | 6.615% | 19.244% | 13.242% | 0.560% | 8.452% |
| 总债项 / 股东资金比率 (%) | 76.324% | 119.544% | 82.702% | 75.887% | 39.577% |
| 长期债项 / 股东资金比率 (%) | 19.877% | 38.046% | 31.685% | 32.545% | 30.111% |
| 净债项 / 股东资金比率 (%) | 14.791% | 62.448% | 35.203% | 1.573% | 21.032% |
| 净现金 / (债项) ($) | (2.05亿) | (4.39亿) | (3.16亿) | (1.42千万) | (1.76亿) |
| 每股净现金 / (债项) ($) | (0.114) | (0.257) | (0.190) | (0.009) | -- |
| 总债项 / 资本运用比率 (%) | 54.607% | 67.912% | 49.958% | 40.558% | 21.601% |
| 利息盈利率 (X) | -- | N/A | N/A | N/A | N/A |
营运效率分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 存货周转率日数 (日) | 151.991日 | 127.316日 | 345.115日 | 4391.378日 | -- |
| 应收贸易帐周转率日数 (日) | 22.001日 | 41.494日 | 33.076日 | 71.256日 | N/A |
| 应付贸易帐周转率日数 (日) | 81.983日 | 220.188日 | 302.671日 | 3808.299日 | N/A |
| 备注： | 实时报价更新时间为01/04/2026 17:59 |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |
